Christopher Sparrow
Investitore di Private Equity presso Napier Park Real Assets
Provenienza dei contatti di primo grado di Christopher Sparrow
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
University of Cambridge
122
| College/University | Other Consumer Services | 122 |
The University of Edinburgh
79
| College/University | Other Consumer Services | 79 |
University of Cape Town
39
| College/University | Other Consumer Services | 39 |
Numis Securities Ltd.
 Numis Securities Ltd. Investment Banks/BrokersFinance Numis Securities Ltd. is an institutional brokerage firm headquartered in London, UK. The firm was founded in 1988 and is a subsidiary of Numis Corp. Plc in (LON: NUM). Numis Securities serves as a corporate broker to several clients across all their sectors, ranging from FTSE 100 to FTSE small-cap companies and AIM-listed companies.
22
| Subsidiary | Investment Banks/Brokers | 22 |
Napier Park Real Assets
 Napier Park Real Assets Investment ManagersFinance Napier Park Real Assets (Napier Park Real Assets) is a private equity subsidiary of First Eagle Investment Management LLC. The firm is headquartered in New York.
5
| Subsidiary | Investment Managers | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Christopher Sparrow tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Elliott Advisors (UK) Ltd.
 Elliott Advisors (UK) Ltd. Investment ManagersFinance Elliott Advisors (UK) Ltd. (Elliott UK) is an alternative investment firm headquartered in London, UK. The firm was founded in 1994 and is a subsidiary of Elliott Management Corp., which is owned by Elliott Capital Advisors LP in the US. Elliott UK manages assets of high net worth clients. | Investment Managers | Corporate Officer/Principal | |
| SCORPIO TANKERS INC. | Marine Shipping | Corporate Secretary | |
Morgan Stanley Investment Management Ltd.
 Morgan Stanley Investment Management Ltd. Investment ManagersFinance Morgan Stanley Investment Management Ltd. (MSIM) is an asset management firm headquartered in London, UK. Founded in 1986, the firm is a subsidiary of Morgan Stanley Investments (UK), ultimately held by Morgan Stanley (NYSE: MS) in the US. MSIM offers a range of investment and risk management solutions to institutional and professional investors worldwide. | Investment Managers | Analyst-Equity Analyst-Equity | |
FIL Investment Advisors (UK) Ltd.
 FIL Investment Advisors (UK) Ltd. Investment ManagersFinance FIL Investment Advisors (UK) Ltd. (FIA UK) is a Great Britain-based fund management firm headquartered in Tadworth, Surrey. Founded in 1984, the firm is a wholly-owned subsidiary of FIL Holdings (UK) Limited, which in turn is a wholly-owned subsidiary of FIL Ltd. in Bermuda. FIA UK provides a range of global investment products and services to institutional accounts, mutual funds and other pooled investment vehicles. | Investment Managers | Analyst-Equity | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Oxford | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| Imperial College London | College/University | Undergraduate Degree Doctorate Degree | |
ECI Partners LLP
 ECI Partners LLP Investment ManagersFinance ECI Partners LLP (ECI Partners) is a private equity founded in 1976. The firm is headquartered in London, the United Kingdom with an additional offices in Manchester and New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
Bowmark Capital LLP
 Bowmark Capital LLP Investment ManagersFinance Bowmark Capital LLP (Bowmark Capital) is a private equity firm founded in 1997 by Charles Thomas Messiter Ind. The firm is headquartered in London, UK. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Birmingham | College/University | Undergraduate Degree Graduate Degree | |
| The University of Sydney | College/University | Undergraduate Degree | |
| London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| University of Warwick | College/University | Undergraduate Degree Graduate Degree | |
| University of the Witwatersrand | College/University | Graduate Degree | |
| University of Stellenbosch | College/University | Undergraduate Degree Undergraduate Degree | |
| London Business School | College/University | Masters Business Admin Masters Business Admin | |
| King's College London | College/University | Doctorate Degree Graduate Degree | |
FMR Investment Management (UK) Ltd.
 FMR Investment Management (UK) Ltd. Investment ManagersFinance FMR Investment Management (UK) Ltd. (FMRIM UK) is an investment management firm headquartered in London, UK. The firm was founded in 2006 and is a subsidiary of Fidelity Management & Research Co. LLC (FMR), itself a subsidiary of FMR LLC in the US. FMRIM UK provides investment advisory and portfolio management services as a sub-adviser to certain FMR clients, which includes investment companies in the Fidelity family of mutual funds. | Investment Managers | Analyst-Equity | |
African Infrastructure Investment Managers (Pty) Ltd.
 African Infrastructure Investment Managers (Pty) Ltd. Investment ManagersFinance African Infrastructure Investment Managers (Pty) Ltd. (African Infrastructure Investment Managers) is a private equity firm founded in 2000. The firm is headquartered in Cape Town, Western Cape with additional offices in South Africa, Nigeria, Kenya and Cote d'Ivoire. | Investment Managers | Director/Board Member Private Equity Analyst | |
| Hellman & Friedman LLP | Investment Managers | Private Equity Investor Consultant / Advisor | |
Axxam SpA
 Axxam SpA Miscellaneous Commercial ServicesCommercial Services Axxam SpA provides pharmaceuticals services. The firm specializes in molecular biology, electrophysiology, cellular and biochemical systems. The company was founded by Stefan Lohmer and Alessandro Sidoli in November 2001 and is headquartered in Bresso, Italy. | Miscellaneous Commercial Services | Director/Board Member | |
| Università degli Studi di Napoli Federico II | College/University | Undergraduate Degree | |
Fidelio Capital AB
 Fidelio Capital AB Investment ManagersFinance Fidelio Capital AB (Fidelio Capital) is a private equity firm founded in 2010 by Gabriel Fitzgerald. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Private Equity Investor | |
| Harvard Business School | College/University | Masters Business Admin Graduate Degree Masters Business Admin | |
| HERMITAGE OFFSHORE SERVICES LTD. | Marine Shipping | Corporate Secretary | |
| Cambridge Judge Business School | College/University | Undergraduate Degree Masters Business Admin | |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Investment Managers | Private Equity Investor | |
Ally Bridge Group HK Ltd
 Ally Bridge Group HK Ltd Investment ManagersFinance Ally Bridge Group HK Ltd (Ally Bridge) is a private equity firm founded in 2011 by Frank Yu. The firm is headquartered in Hong Kong with additional office in the US. | Investment Managers | Private Equity Investor | |
Deloitte/Malawi/
 Deloitte/Malawi/ Miscellaneous Commercial ServicesCommercial Services Deloitte/Malawi provides accounting services. The private company is based in Blantyre, Malawi. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Kleoss Capital (Pty) Ltd.
 Kleoss Capital (Pty) Ltd. Investment ManagersFinance Kleoss Capital (Pty) Ltd. (Kleoss Capital) is a private equity firm founded in 2014 by Halekopane Matsipa. The firm is headquartered in Gauteng, South Africa. | Investment Managers | Director of Finance/CFO | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| LAPCO HOLDINGS LIMITED | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
LifeQ, Inc.
 LifeQ, Inc. Internet Software/ServicesTechnology Services LifeQ, Inc. operates as a health informatics company. Its bio-mathematical engine can ingest various data streams (continuous, periodic, episodic and/or static physiological data streams) to construct a highly personalized and accurate digital representation of an individual’s unique physiology. The company was founded by Laurence Olivier, Riaan Conradie, Kora Holm, and Franco Du Preez and is headquartered in Alpharetta, GA. | Internet Software/Services | Director/Board Member | |
| AZITRAPAR | Pharmaceuticals: Major | Director/Board Member | |
GRO Biosciences, Inc.
 GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| Kohlberg Kravis Roberts & Co. Partners LLP | Investment Managers | Private Equity Investor | |
Khloris Biosciences, Inc.
 Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Biotechnology | Director/Board Member | |
Vesigen, Inc.
 Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Mozart Therapeutics, Inc.
 Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | Biotechnology | Director/Board Member | |
| Leaps By Bayer /US/ | Investment Managers | Private Equity Investor | |
Charm Therapeutics Ltd.
 Charm Therapeutics Ltd. BiotechnologyHealth Technology Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then. | Biotechnology | Director/Board Member | |
AviadoBio Ltd.
 AviadoBio Ltd. BiotechnologyHealth Technology AviadoBio Ltd. is a gene therapy company based in London, UK. AviadoBio's technology is based on pioneering research from King's College London and the UK Dementia Research Institute. The British company's mission is to develop and deliver transformative gene therapies for neurodegenerative disorders, including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company is developing AVB-101 for patients with FTD-GRN. AviadoBio's investors include New Enterprise Associates (NEA), Monograph Capital, Advent Life Sciences, EQT Lifesciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and LifeArc. The company was founded by Youn Bok Lee, Do Young Lee, Chris E. Shaw, and Lisa Deschamps has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Leon Capital LLP
 Leon Capital LLP Investment ManagersFinance Leon Capital LLP (Leon Capital) is a private equity firm founded by Jean-Christophe Napoléon Bonaparte, Christos Lavidas and Michael Youtsos. The firm is headquartered in. | Investment Managers | Founder | |
| Charm Therapeutics, Inc. | Director/Board Member |
Statistiche
Distribuzione geografica
| Regno Unito | 22 |
| Stati Uniti | 16 |
| Sud Africa | 5 |
| Italia | 3 |
| Monaco | 2 |
Settori
| Finance | 17 |
| Consumer Services | 15 |
| Health Technology | 10 |
| Commercial Services | 7 |
| Transportation | 3 |
Posizioni
| Director/Board Member | 116 |
| Undergraduate Degree | 78 |
| Graduate Degree | 61 |
| Corporate Officer/Principal | 58 |
| Private Equity Investor | 57 |
Contatti più connessi
| Insiders | |
|---|---|
| Joseph C. Lane | 24 |
| Manu S. Rana | 20 |
| Lucio Iannone | 17 |
| Erelu Adebayo | 15 |
| Bora Oruc | 12 |
| Christopher Kelly | 12 |
| Daniel Graf von der Schulenburg | 10 |
| Kwok Kei Mak | 9 |
| Deviyani Godwin | 9 |
| Chris Baker | 8 |
| Fan Yang | 8 |
| Adrien Motte | 8 |
| Cinney Zhang | 7 |
| Luke Smith | 7 |
| Liam Goddard | 7 |
- Borsa valori
- Insiders
- Christopher Sparrow
- Connessioni Società
